首页> 美国卫生研究院文献>PLoS Clinical Trials >FAM-MDR: A Flexible Family-Based Multifactor Dimensionality Reduction Technique to Detect Epistasis Using Related Individuals
【2h】

FAM-MDR: A Flexible Family-Based Multifactor Dimensionality Reduction Technique to Detect Epistasis Using Related Individuals

机译:FAM-MDR:一种灵活的基于家庭的多维度降维技术可使用相关个体检测上皮

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We propose a novel multifactor dimensionality reduction method for epistasis detection in small or extended pedigrees, FAM-MDR. It combines features of the Genome-wide Rapid Association using Mixed Model And Regression approach (GRAMMAR) with Model-Based MDR (MB-MDR). We focus on continuous traits, although the method is general and can be used for outcomes of any type, including binary and censored traits. When comparing FAM-MDR with Pedigree-based Generalized MDR (PGMDR), which is a generalization of Multifactor Dimensionality Reduction (MDR) to continuous traits and related individuals, FAM-MDR was found to outperform PGMDR in terms of power, in most of the considered simulated scenarios. Additional simulations revealed that PGMDR does not appropriately deal with multiple testing and consequently gives rise to overly optimistic results. FAM-MDR adequately deals with multiple testing in epistasis screens and is in contrast rather conservative, by construction. Furthermore, simulations show that correcting for lower order (main) effects is of utmost importance when claiming epistasis. As Type 2 Diabetes Mellitus (T2DM) is a complex phenotype likely influenced by gene-gene interactions, we applied FAM-MDR to examine data on glucose area-under-the-curve (GAUC), an endophenotype of T2DM for which multiple independent genetic associations have been observed, in the Amish Family Diabetes Study (AFDS). This application reveals that FAM-MDR makes more efficient use of the available data than PGMDR and can deal with multi-generational pedigrees more easily. In conclusion, we have validated FAM-MDR and compared it to PGMDR, the current state-of-the-art MDR method for family data, using both simulations and a practical dataset. FAM-MDR is found to outperform PGMDR in that it handles the multiple testing issue more correctly, has increased power, and efficiently uses all available information.
机译:我们提出了一种新颖的多因素降维方法,用于在小谱系或扩展谱系中的上位性检测FAM-MDR。它结合了使用混合模型和回归方法(GRAMMAR)的全基因组快速关联的功能以及基于模型的MDR(MB-MDR)。尽管该方法是通用方法,并且可用于任何类型的结果,包括二元和删节性状,但我们仍专注于连续性状。当将FAM-MDR与基于谱系的广义MDR(PGMDR)进行比较时,PGMDR是对连续特征和相关个体的多维度降维(MDR)的概括,发现FAM-MDR在力量方面优于PGMDR。考虑模拟场景。其他模拟显示,PGMDR无法适当地应对多种测试,因此会导致过于乐观的结果。 FAM-MDR足够处理上位性筛查中的多种测试,相反,通过构造,它相当保守。此外,模拟表明,在声称具有上位性时,纠正低阶(主要)效应至关重要。由于2型糖尿病(T2DM)是可能受基因-基因相互作用影响的复杂表型,因此我们应用FAM-MDR来检查血糖曲线下面积(GAUC)的数据,该曲线是T2DM的内表型,具有多个独立的遗传因素在阿米什人糖尿病研究(AFDS)中观察到了相关性。该应用程序表明,FAM-MDR比PGMDR更有效地利用了可用数据,并且可以更轻松地处理多代谱系。总之,我们已经使用模拟和实用数据集验证了FAM-MDR并将其与PGMDR(当前用于家庭数据的最新MDR方法)进行了比较。发现FAM-MDR优于PGMDR,因为它可以更正确地处理多重测试问题,增强功能并有效地使用所有可用信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号